These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 17768117

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Hypereosinophilic syndrome in a myeloproliferative variety. Success after 18 month treatment with interferon alpha].
    Dine G, Najman A, Brahimi S, Culioli B, Abid A, Dupoirieux J.
    Presse Med; 1992 Nov 07; 21(37):1776. PubMed ID: 1488427
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Case of polycythemia vera concurrent with FIP1L1-PDGFRA-positive myeloproliferative neoplasm with eosinophilia.
    Alrwas A, Quesada JR, Marcos LA, Mehta SS, Shattuck BL, Nguyen ND, Juneja HS.
    Cancer Genet; 2012 Oct 07; 205(10):519-22. PubMed ID: 22944561
    [Abstract] [Full Text] [Related]

  • 7. Successful allogeneic stem cell transplantation with long-term remission of ETV6/FLT3-positive myeloid/lymphoid neoplasm with eosinophilia.
    Chonabayashi K, Hishizawa M, Matsui M, Kondo T, Ohno T, Ishikawa T, Takaori-Kondo A.
    Ann Hematol; 2014 Mar 07; 93(3):535-7. PubMed ID: 23873282
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Unusual infant eosinophilia: myeloid neoplasm with FGFR1 abnormality.
    Li W, Cooley LD.
    Blood; 2016 Sep 08; 128(10):1440. PubMed ID: 27769039
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Case 1-2013: fatal manifestation of myeloproliferative disease.
    Sevcíková H, Pelouch R, Matejková A, Dulícek P.
    Acta Medica (Hradec Kralove); 2013 Sep 08; 56(1):33-5. PubMed ID: 23909053
    [No Abstract] [Full Text] [Related]

  • 13. [Differential diagnosis of eosinophilia in combination with intoxication syndrome].
    Egorov IV, Kotina LN.
    Klin Med (Mosk); 2004 Sep 08; 82(8):70-2. PubMed ID: 15468731
    [No Abstract] [Full Text] [Related]

  • 14. SOHO State of the Art Updates and Next Questions | Myeloid/Lymphoid Neoplasms with Eosinophilia and Gene Rearrangements: Diagnostic Pearls and Pitfalls.
    Kim AS, Pozdnyakova O.
    Clin Lymphoma Myeloma Leuk; 2022 Sep 08; 22(9):643-651. PubMed ID: 35478091
    [Abstract] [Full Text] [Related]

  • 15. Intrauterine diagnosis and management of transient myeloproliferative disorder.
    Strobelt N, Ghidini A, Locatelli A, Vergani P, Mariani S, Biondi A.
    Am J Perinatol; 1995 Mar 08; 12(2):132-4. PubMed ID: 7779196
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Development and application of novel immunoassays for eosinophil granule major basic proteins to evaluate eosinophilia and myeloproliferative disorders.
    Squillace DL, Checkel JL, Tefferi A, Kita H, Gleich GJ.
    J Immunol Methods; 2021 Jun 08; 493():113015. PubMed ID: 33689807
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Eosinophilic dermatosis of myeloproliferative disease: characterization of a unique eruption in patients with hematologic disorders.
    Byrd JA, Scherschun L, Chaffins ML, Fivenson DP.
    Arch Dermatol; 2001 Oct 08; 137(10):1378-80. PubMed ID: 11594874
    [No Abstract] [Full Text] [Related]

  • 20. Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders.
    Valent P.
    Blood Rev; 2009 Jul 08; 23(4):157-65. PubMed ID: 19246139
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.